Allspring Global Investments’s Albireo Pharma Inc ALBO Stock Holding History

Allspring Global Investments’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,000	Closed	-$21.6K	–	2999
2022 Q4	$21.6K	Sell	1,000 -640	-39%	-$13.5K	﹤0.01%	2574
2022 Q3	$31K	Buy	1,640 +1,031	+169%	+$21.3K	﹤0.01%	2513
2022 Q2	$12K	Buy	609 +439	+258%	+$11.6K	﹤0.01%	2563
2022 Q1	$5K	Buy	+170	New	+$4.98K	﹤0.01%	2985

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Allspring Global Investments's ALBO Position: Q1 2023 in Review

Allspring Global Investments sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 1,000 shares — an estimated $21.6K sold.

Allspring Global Investments first reported a position in ALBO in Q1 2022 and held it in 4 quarters. The position peaked at $31K in Q3 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Allspring Global Investments reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Allspring Global Investments sold 1,000 Albireo Pharma Inc shares in Q1 2023, an estimated $21.6K.
Allspring Global Investments first reported a position in Albireo Pharma Inc in Q1 2022 and held it in 4 quarters.
Allspring Global Investments's Albireo Pharma Inc position peaked at $31K in Q3 2022.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Allspring Global Investments's 13F filing for Q1 2023, filed 13 Apr 2023.